The Magazine for Sleep Professionals
Thursday, October 15, 2026
Vivos Therapeutics, Inc., a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, including obstructive sleep apnea (OSA), announced the launch of VivoScore, powered by SleepImage®. VivoScore is a comprehensive home sleep apnea test (“HSAT”) that utilizes proprietary cardiopulmonary coupling technology developed by […]
A new study found that treating obstructive sleep apnea with CPAP therapy increased self-reported physical activity in adults with a history of heart disease. During a mean follow-up period of 3.7 years, the group treated with CPAP therapy reported approximately 20% higher levels of moderate physical activity compared with the control group. […]
Signifier Medical Technologies, an innovator in the sleep-disordered breathing market announced that eXciteOSA®, the first and only daytime intraoral neuromuscular stimulation device for treating mild obstructive sleep apnea and snoring, has been cleared by the U.S. Food and Drug Administration (FDA), giving millions of sufferers in the U.S. access to […]
Researchers at the University of Eastern Finland and Kuopio University Hospital developed a new neural network that enables an easy and accurate assessment of sleep apnea severity in patients with cerebrovascular disease. The assessment is automated and based on simple nocturnal pulse oximetry, making it possible to easily screen for […]
Since sovaSage Incorporated, a Pittsburgh based company, first announced its new zero contact patient management software, TherapistAssist™, in October of this year, this revolutionary means of managing CPAP patients using its patent-pending telemedicine technology is taking hold. “The industry’s response to our product has been like nothing that I have […]
A new study by Monash University in Melbourne, Australia, has found that obstructive sleep apnea (OSA) has been linked to an increased risk of dementia. The study, published in the Journal of Alzheimer’s Disease, and led by Dr. Melinda Jackson from the Turner Institute for Brain and Mental Health, found that […]
Sommetrics, a private company developing products and services to improve sleep health, has announced its lead sleep apnea product, aerSleep II, has received FDA Breakthrough Device designation. This program allows for additional FDA feedback to sponsors during the pre-marketing phase but does not alter the basic requirements for market authorization. […]
Lune, a holistic training and monitoring system for people with sleep apnea trouble, encourages a sound sleep by stimulating oral muscles around the throat by means of pulsating electrodes. Inspired by the male frog’s mate calling technique, which is when the male frog lifts his head upwards in order to […]
Masimo announced the findings of an abstract recently presented at ANESTHESIOLOGY® 2020, the Annual Meeting of the American Society of Anesthesiologists (ASA). In this independent, retrospective study, researchers investigated whether Masimo ORi™ (Oxygen Reserve Index) could predict whether children with obstructive sleep apnea syndrome (OSAS) undergoing tonsillectomy required postoperative oxygen therapy. […]
Transplanted bacteria from sleep-apnea mice caused sleep changes in recipient mice Evidence suggests OSA can alter the gut microbiome (GM) and may promote OSA-associated co-morbidities, including diabetes, hypertension, and cognitive problems. Researchers from the University of Missouri School of Medicine and MU Health Care have discovered how OSA-related sleep disturbances affect the gut microbiome in mice […]
